<DOC>
	<DOCNO>NCT02546583</DOCNO>
	<brief_summary>Effective diuresis primary goal acute decompensated heart failure hospitalization , diuretic resistance common ability detect limit . Further , therapeutically distinct group diuretic-resistant patient . These easily distinguish use currently available method , lead trial-and-error base treatment promote lengthy hospitalization . The aim study : 1 . To develop inexpensive efficient tool predict diuretic response 2 . To understand prevalence therapeutically targetable mechanism diuretic resistance use endogenous lithium clearance 3 . To develop methodology differentiate diuretic resistance mechanism use common/inexpensive laboratory test 4 . To provide proof concept mechanistically tailor diuretic therapy improve natriuresis</brief_summary>
	<brief_title>Diagnosing Targeting Mechanisms Diuretic Resistance Heart Failure</brief_title>
	<detailed_description>This study minimal-risk observational open-label single center study randomization two standard care intervention . Approximately 200 patient admitted hospital ( Yale New Haven Health System ) clinical diagnosis heart failure enrol overall study . Patients undergo sample blood urine minimum 4 timepoints ( 5 interventional arm ) . Patients low urine sodium output ( &lt; 100 mmol ) Visit 1 eligible 1:1 randomization either increase dose Visit 1 loop diuretic addition IV chlorothiazide Visit 1 loop diuretic .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Bumetanide</mesh_term>
	<mesh_term>Chlorothiazide</mesh_term>
	<mesh_term>Sodium Potassium Chloride Symporter Inhibitors</mesh_term>
	<criteria>For patient : Clinical diagnosis ADHF least one objective sign volume overload ( rale , edema , elevate JVP , preadmission weight gain ) For patient interventional arm : A projected need treat physician continue treatment IV diuretic least 3 day goal significant fluid removal ( &gt; 1L net fluid loss/day ) Production &lt; 100 mmol sodium output Visit 1 study Serum sodium &gt; 125 mmol/L Study Visit 1 loop diuretic dose â‰¤ 160 mg furosemide equivalent At least 6 hour since last dose diuretic Significant bladder dysfunction urinary incontinence Inability comply serial urine collection procedure return 57 day post discharge study visit Current use project future requirement treat physician thiazide diuretic Use high dose mineralocorticoid receptor antagonist therapy ( &gt; 50mg spironolactone &gt; 100mg eplerenone ) amiloride</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>